dupilumab
SpainDrugs containing this active substance
-
It is used to treat atopic dermatitis (eczema) in adults, adolescents, and children; severe asthma in adults, adolescents, and children aged 6 years and older; eosinophilic esophagitis in adults, adolescents, and children aged 1 year and older (with a minimum weight of 15 kg); and chronic spontaneous urticaria in adults, adolescents, and children aged 2 years and older.
Form: solution for injection
Active substance Dosage dupilumab 200 mg Manufacturer: Sanofi Winthrop Industrie
-
It is used to treat moderate to severe atopic dermatitis (eczema) in adults, adolescents, and children; severe asthma in adults, adolescents, and children from 6 years of age; eosinophilic esophagitis in adults, adolescents, and children from 1 year of age; and chronic spontaneous urticaria in adults, adolescents, and children from 2 years of age.
Form: solution for injection
Active substance Dosage dupilumab 200 mg Manufacturer: Sanofi Winthrop Industrie
-
It is used to treat various conditions such as atopic dermatitis (eczema), severe asthma, chronic rhinosinusitis with nasal polyps, prurigo nodularis, eosinophilic esophagitis, chronic obstructive pulmonary disease (COPD), and chronic spontaneous urticaria.
Form: solution for injection
Active substance Dosage dupilumab 300 mg Manufacturer: Sanofi Winthrop Industrie
-
It is used to treat various conditions such as atopic dermatitis (eczema), severe asthma, chronic rhinosinusitis with nasal polyps, prurigo nodularis, eosinophilic esophagitis, chronic obstructive pulmonary disease (COPD), and chronic spontaneous urticaria.
Form: solution for injection
Active substance Dosage dupilumab 300 mg Manufacturer: Sanofi Winthrop Industrie